Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 1,000 shares at $101.11 ($100K) on 2021-09-13, disclosed to the SEC on 2021-09-15.
Scheduled sale ($100k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.62 | 8 | $781 | 0.8% |
| 2 | $98.41 | 28 | $3K | 2.8% |
| 3 | $99.25 | 417 | $41K | 41.4% |
| 4 | $99.98 | 261 | $26K | 26.1% |
| 5 | $101.11 | 286 | $29K | 28.9% |
| Total | $99.94 avg | 1,000 |
| $100K |
| 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |